Showing 601 - 620 results of 133,918 for search '(( a d decrease ) OR ( 5 ((((non decrease) OR (point decrease))) OR (a decrease)) ))', query time: 1.81s Refine Results
  1. 601
  2. 602

    The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

    Published 2017
    “…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”
  3. 603

    Influence of the Lactotripeptides Isoleucine–Proline–Proline and Valine–Proline–Proline on Systolic Blood Pressure in Japanese Subjects: A Systematic Review and Meta-Analysis of Ra... by Aurelie Chanson-Rolle (758940)

    Published 2015
    “…Furthermore, the effect of IPP/VPP on SBP remained significant when limiting the analysis to series that tested the usual doses of IPP/VPP consumed daily (below 5 mg/d), with estimated effects of -6.01 mm Hg in the overall population and -3.32 mm Hg in non-hypertensive subjects.…”
  4. 604

    Functional characterization of the V9D and R10C substitutions in chicken ARF. by Doreen Schwochow Thalmann (3912649)

    Published 2017
    “…In the experiment, ARF peptides (WT, V9D, and R10C, respectively) were titrated into 100 μM MDM2<sub>204-298</sub> with the peptide concentration increasing by approximately 10 μM in each titration point. …”
  5. 605
  6. 606

    The ATR IR signal decreases with decreasing dilutions of cells. by Allison L. Stelling (392086)

    Published 2013
    “…<p>Shown is a box plot for serial dilutions of a glioblastoma cell suspension. …”
  7. 607
  8. 608
  9. 609
  10. 610
  11. 611

    Rab7A decreases BST2 cell surface expression and is required for Vpu-induced BST2 cell surface downregulation. by Marina Caillet (198168)

    Published 2011
    “…<p>(<b>A</b>–<b>B</b>) Rab7A decreases BST2 cell surface expression. …”
  12. 612
  13. 613

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …”
  14. 614

    Pharmacological Mechanism of the Non-hallucinogenic 5‑HT<sub>2A</sub> Agonist Ariadne and Analogs by Michael J. Cunningham (14267038)

    Published 2022
    “…Ariadne is a non-hallucinogenic analog in the phenylalkylamine chemical class of psychedelics that is closely related to an established synthetic hallucinogen, 2,5-dimethoxy-4-methyl-amphetamine (DOM), differing only by one methylene group in the α-position to the amine. …”
  15. 615
  16. 616

    Decreased brain glucose uptake and glucose transporter expressions at early stage of female aging. by Fan Ding (302565)

    Published 2013
    “…D. In nonTg hippocampus, there was a trend towards increased expression of GLUT1<sub>45 Kda</sub> from 3 to 12 months of age. …”
  17. 617
  18. 618
  19. 619
  20. 620